Learning Objective

 

The following learning objectives will be addressed:


OB Hemorrhage Safety Update

  1. Use of uterontonic agents for uterine atony
  2. Role of fibrinogen in the diagnosis and management of hemorrhage
  3. Efficacy and safety of TXA for postpartum bleeding
  4. Risk factors associated with obstetric hemorrhage

 

Pediatrics
  1. PediatricsDescribe the metabolic pathways associated with codeine toxicity.
  2. Summarize alternatives to codeine in perioperative management of post-tonsillectomy pain.
  3. Assess the evidence related to the recent FDA warning on anesthetic neurotoxicity
  4. Explain the consensus statement of the Society for Pediatric Anesthesia responding to the FDA Medwatch.